EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

RHO -Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model – In Preparation for Clinical Trials

Malena Daich Varela, Juan Carlos Romo-Aguas, Rosellina Guarascio, Kalliopi Ziaka, Monica Aguila, Kwan-Leong Hau, Yumei Li, Rui Chen, Angelos Kalitzeos, Anthony G Robson, Rebecca A Baker, Omar A Mahroo and 6 more

Investigative Ophthalmology & Visual Science · 2025-07-30 · 66 (9) · 69

DOI: 10.1167/iovs.66.9.69 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published online on 2025-07-30. Written by Malena Daich Varela and 17 co-authors. Institution: Moorfields Eye Hospital, London, United Kingdom. Major MEDLINE topics: Retinitis Pigmentosa, Rhodopsin, Mutation. Cited 14 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

The purpose of this study was to describe the largest cohort of RHO-associated retinitis pigmentosa (RP) to date, analyzing the spectrum of phenotypes, variants, disease natural history, and genotype-phenotype correlations.

Methods

Variants were classified using functional assays, animal models, and published data. Clinical assessments involved visual acuity (LogMAR), dilated fundus examinations, multimodal imaging (spectral-domain optical coherence tomography [SD-OCT] and fundus autofluorescence [FAF]), and international-standard electrophysiology. Cases were described as having generalized RP or sector RP according to fundus examination and imaging data. Longitudinal analysis evaluated progression rates of visual and structural parameters.

Results

Two hundred patients (140 families) with likely disease-causing variants in RHO were identified. Positive family history was documented in 78.5% of the cases. Generalized RP was diagnosed in 64%, sector RP in 34.5%, and 1.5% were asymptomatic carriers. Fifty-six variants were identified, 54% were classified as class 2, 14% as class 1, 5% as class 4, and 2% as class 3. Variants in class 1 were associated with earlier symptom onset (mean = 13.5 years), generalized RP, and the worst baseline visual acuity (mean LogMAR = 0.45). Pro347Leu was the most prevalent variant (17%). Longitudinal analysis showed slower progression in sector RP (0.01 LogMAR/year) compared to generalized RP (0.03 LogMAR/year). Imaging revealed distinct phenotypes, including choroideremia-like features in generalized RP and inferior retinal involvement in sector RP that an animal model suggests is light related.

Conclusions

RHO-associated RP encompasses a wide phenotypic spectrum with distinct genetic subtypes influencing disease severity and progression. These findings provide critical insights for patient counseling, identifying clinical endpoints, participant stratification, and guiding therapeutic development.

Subjects

MeSH terms (MEDLINE)

Retinitis PigmentosaRhodopsinMutationHumansMalePhenotypeFemaleTomography, Optical CoherenceDisease Models, AnimalVisual AcuityAnimalsMiddle AgedAdultElectroretinographyDisease ProgressionAdolescentYoung AdultFluorescein AngiographyGenetic Association StudiesAgedPedigreeClinical Trials as Topic

Substances

Rhodopsin

Authors and institutions

  • Moorfields Eye Hospital, London, United Kingdom.
  • UCL Institute of Ophthalmology, University College London, London, United Kingdom.
  • Gavin Herbert Eye Institute - Center for Translational Vision Research, Department of Ophthalmology, University of California Irvine School of Medicine, Irvine, California, United States.
  • Octant, Inc., Emeryville, California, United States.

Funding

  • Wellcome Trust

Cite

APA

Daich Varela, M., Romo-Aguas, J. C., Guarascio, R., Ziaka, K., Aguila, M., Hau, K. L., Li, Y., Chen, R., Kalitzeos, A., Robson, A. G., Baker, R. A., Mahroo, O. A., Webster, A. R., Chan, H., Lubock, N. B., Albert, M. L., Cheetham, M. E., & Michaelides, M. (2025). RHO -Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model – In Preparation for Clinical Trials. Investigative Ophthalmology & Visual Science, 66(9), 69. https://doi.org/10.1167/iovs.66.9.69

Vancouver

Daich Varela M, Romo-Aguas JC, Guarascio R, Ziaka K, Aguila M, Hau KL, et al. RHO -Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model – In Preparation for Clinical Trials. Investigative Ophthalmology & Visual Science. 2025;66(9):69. doi:10.1167/iovs.66.9.69

BibTeX
@article{DaichVarela2025,
  author = {Daich Varela, Malena and Romo-Aguas, Juan Carlos and Guarascio, Rosellina and Ziaka, Kalliopi and Aguila, Monica and Hau, Kwan-Leong and Li, Yumei and Chen, Rui and Kalitzeos, Angelos and Robson, Anthony G and Baker, Rebecca A and Mahroo, Omar A and Webster, Andrew R and Chan, Henry and Lubock, Nathan B and Albert, Matthew L and Cheetham, Michael E and Michaelides, Michel},
  title = {RHO -Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model – In Preparation for Clinical Trials},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {9},
  pages = {69},
  doi = {10.1167/iovs.66.9.69}
}
Start for free →